Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Molecular Hepatology|March 25, 2026
From Steatosis to Metastasis: Microenvironmental Reprogramming of the Liver in MASLDGyu Jeong Cho, Sun Myoung Kim, Yoon Mee Yang, et al.
Hepatology (Baltimore, Md.)|July 19, 2012
Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoidYoon Mee Yang, So Yeon Seo, Tae Hyun Kim, et al.
World Journal of Gastroenterology|August 11, 2010
AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viabilityYoon Mee Yang, Chang Yeob Han, Yoon Jun Kim, et al.
Archives of Biochemistry and Biophysics|July 18, 2009
Metadoxine, an ion-pair of pyridoxine and L-2-pyrrolidone-5-carboxylate, blocks adipocyte differentiation in association with inhibition of the PKA-CREB pathwayYoon Mee Yang, Hyun Eun Kim, Sung Hwan Ki, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathwayEun Ju Bae, Yoon Mee Yang, Jin Wan Kim, et al.
Experimental & Molecular Medicine|June 25, 2020
Gα12/13 signaling in metabolic diseasesYoon Mee Yang, Da-Sol Kuen, Yeonseok Chung, et al.
Biomolecules & Therapeutics|October 11, 2024
Atractylodes Lancea and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK ActivationGa Yeon Song, Sun Myoung Kim, Seungil Back, et al.
Frontiers in Endocrinology|August 8, 2018
Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic SteatohepatitisYoon Mee Yang, Masato Fukui, Zhijun Wang, et al.
Oncotarget|February 26, 2015
Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agentsJung Min Lee, Mi Jeong Heo, Chan Gyu Lee, et al.
International Journal of Cancer|September 7, 2017
The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted miceIsabelle Jingyi Song, Yoon Mee Yang, Sayaka Inokuchi-Shimizu, et al.
Pageof 5